290 related articles for article (PubMed ID: 20582424)
1. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
Valentová J; Bauerová K; Farah L; Devínsky F
Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
[TBL] [Abstract][Full Text] [Related]
2. Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin.
Kommuru TR; Khan MA; Reddy IK
Chirality; 1999; 11(7):536-40. PubMed ID: 10423279
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
[TBL] [Abstract][Full Text] [Related]
4. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
Charoo NA; Shamsher AA; Kohli K; Pillai K; Rahman Z
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):300-7. PubMed ID: 18579348
[TBL] [Abstract][Full Text] [Related]
5. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
6. Involvement of organic anion transport system in transdermal absorption of flurbiprofen.
Ito K; Kato Y; Tsuji H; Nguyen HT; Kubo Y; Tsuji A
J Control Release; 2007 Dec; 124(1-2):60-8. PubMed ID: 17884233
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
8. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient.
Suedee R; Brain KR; Heard CM
Chirality; 1999; 11(9):680-3. PubMed ID: 10506427
[TBL] [Abstract][Full Text] [Related]
9. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.
Eeckhoudt SL; Evrard PA; Verbeeck RK
Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the transdermal transport of flurbiprofen and indomethacin.
Li Q; Tsuji H; Kato Y; Sai Y; Kubo Y; Tsuji A
J Control Release; 2006 Feb; 110(3):542-56. PubMed ID: 16380188
[TBL] [Abstract][Full Text] [Related]
11. Chiral 4-
Chu T; Wang C; Wang J; Wang H; Geng D; Wu C; Zhao L; Zhao L
Drug Deliv; 2020 Dec; 27(1):723-735. PubMed ID: 32397753
[TBL] [Abstract][Full Text] [Related]
12. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
Fang JY; Hung CF; Chi CH; Chen CC
Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
[TBL] [Abstract][Full Text] [Related]
13. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport.
Uchino T; Murata A; Miyazaki Y; Oka T; Kagawa Y
Chem Pharm Bull (Tokyo); 2015; 63(5):334-40. PubMed ID: 25948327
[TBL] [Abstract][Full Text] [Related]
14. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
16. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of flurbiprofen microemulsion.
Ambade KW; Jadhav SL; Gambhire MN; Kurmi SD; Kadam VJ; Jadhav KR
Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
[TBL] [Abstract][Full Text] [Related]
18. Fatty acids in Botryococcus braunii accelerate topical delivery of flurbiprofen into and across skin.
Fang JY; Chiu HC; Wu JT; Chiang YR; Hsu SH
Int J Pharm; 2004 May; 276(1-2):163-73. PubMed ID: 15113623
[TBL] [Abstract][Full Text] [Related]
19. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R; Desu H; Jain A; Khandavilli S
Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
[TBL] [Abstract][Full Text] [Related]
20. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
